Greenyn Biotechnology Co., Ltd. engages in the research, development, manufacture and sales of health food raw materials. Its products include solid-state antrodia cinnamomea mycelia, bitter gourd peptide, and 101 comprehensive vegetable and fruit fermentation broth. The company was founded on July 18, 2012 and is headquartered in Taichung, Taiwan.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company